ValiRx plc (LON:VAL – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 3.74 ($0.05) and traded as low as GBX 2.40 ($0.03). ValiRx shares last traded at GBX 2.45 ($0.03), with a volume of 183,055 shares changing hands.
ValiRx Stock Performance
The company’s 50-day moving average price is GBX 2.79 and its two-hundred day moving average price is GBX 3.72. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.27 and a current ratio of 2.64. The stock has a market cap of £3.24 million, a PE ratio of -122.50 and a beta of 0.63.
About ValiRx
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer.
Recommended Stories
- Five stocks we like better than ValiRx
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why This AI Stock is Rising Despite Tech Sell-Off
- Canada Bond Market Holiday: How to Invest and Trade
- Investors Are Moving into Bonds and Small Cap Stocks: Here’s Why
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 7/15 – 7/19
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
